OBALON THERAPEUTICS, INC.

Company

Vyome Holdings, Inc

Filed

August 6, 2019

Accession Number

0000902664-19-003227

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →